Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Neoanhydropodophyllol

Cat. No.: IBDI-430867

Neoanhydropodophyllol is a cyclolignan derivative, with antineoplastic activity. Neoanhydropodophyllol displays cytotoxicity against several cancer cells (leukemia, lung carcinoma and colon carcinoma).

Size (Solid):

Product Details

Target Others
Molecular Weight 400.42
Appearance Solid
SMILES OC[[email protected]@H]1[[email protected]]2([H])C3=CC(OCO4)=C4C=C3[[email protected]@H](C5=CC(OC)=C(OC)C(OC)=C5)[[email protected]@]1([H])CO2
Structure Classification Phenylpropanoids>Lignans
Purity 99.61%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.